The Society has learned that longtime member Narendra Dhanraj Lalwani, PhD, MBA, passed away on October 11, 2024. Dr. Lalwani was a pharmaceutical executive with experience at Pfizer, Cerenis Therapeutics, and Esperion Therapeutics.
This blog serves as an announcement of the member’s passing. Family, friends, and colleagues are welcome to develop a more detailed tribute for publication by SOT.